74
Participants
Start Date
June 25, 2014
Primary Completion Date
August 14, 2016
Study Completion Date
August 14, 2016
Bupropion XL 300
"Subjects will be studied in 4 phases for a total of approximately 28 weeks:~Phase 1: an approximately 4-week lead-in phase during which participants remain on their existing bupropion product Phases 2 - 4: randomized cross-over phases of approximately 6 weeks on each of the four bupropion study drugs (brand and 3 generics)."
Washington University School of Medicine, St Louis
Washington University School of Medicine
OTHER